Saba Capital Management, L.P. bought HQL
May 7, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 50,161 shares of Abrdn Life Sciences Investors at $13.76 per share, a transaction worth $690.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,161
Price
$13.76
Total value
$690.2K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 7, 2024
Filing dateMay 7, 2024
Shares owned after3,129,604
OwnershipIndirect
10b5-1 planNo
AmendedNo